Literature DB >> 18568493

HOX-GFP and WOX-GFP lentivirus vectors for inner ear gene transfer.

Laura Pietola1, Antti A Aarnisalo, Joonas Joensuu, Riikka Pellinen, Jarmo Wahlfors, Jussi Jero.   

Abstract

CONCLUSION: GFP transgene was expressed in the lining cells of the perilymphatic space. Lentivirus vectors are safe and cause only minimal inflammatory reaction. Transgene products can be delivered into the perilymph by utilizing lentivirus vectors.
OBJECTIVES: To analyze the efficiency and safety of lentiviral vectors HOX-GFP and WOX-GFP in intracochlear gene transfer.
MATERIALS AND METHODS: Lentivirus vectors were tested for their transduction efficiency in vivo in CD-1 mice. Half of the animals were pretreated with kanamycin. Lentivirus vector or saline (1 microl) was injected into the inner ear. All the animals were sacrificed 14 days after the surgery and the cochleae and selected organs were analyzed immunohistochemically.
RESULTS: HOX-GFP and WOX-GFP expression was restricted to the lining cells of the scala tympani and scala vestibuli. No GFP expression was seen in the organ of Corti or the spiral ganglion. Aminoglycoside treatment had no effect on the expression of these vectors. The distant spread of lentivirus vectors was minimal; only the liver of one animal showed some GFP expression. Inflammatory reaction caused by these vectors was mild. Few inflammatory cells were found in the perilymphatic space of the cochlea and in the vestibular organ.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18568493     DOI: 10.1080/00016480701663409

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  10 in total

1.  Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice.

Authors:  Jing-Ying Guo; Lu He; Teng-Fei Qu; Yu-Ying Liu; Ke Liu; Guo-Peng Wang; Shu-Sheng Gong
Journal:  J Vis Exp       Date:  2018-05-25       Impact factor: 1.355

2.  The spread of adenoviral vectors to central nervous system through pathway of cochlea in mimetic aging and young rats.

Authors:  X Chen; X Zhao; Y Hu; F Lan; H Sun; G Fan; Y Sun; J Wu; W Kong; W Kong
Journal:  Gene Ther       Date:  2015-06-30       Impact factor: 5.250

3.  p27Kip1 knockdown induces proliferation in the organ of Corti in culture after efficient shRNA lentiviral transduction.

Authors:  Juan C Maass; F Andrés Berndt; José Cánovas; Manuel Kukuljan
Journal:  J Assoc Res Otolaryngol       Date:  2013-04-24

Review 4.  Emerging Gene Therapies for Genetic Hearing Loss.

Authors:  Hena Ahmed; Olga Shubina-Oleinik; Jeffrey R Holt
Journal:  J Assoc Res Otolaryngol       Date:  2017-08-16

Review 5.  Advances in genome editing for genetic hearing loss.

Authors:  Ning Ding; Sangsin Lee; Matan Lieber-Kotz; Jie Yang; Xue Gao
Journal:  Adv Drug Deliv Rev       Date:  2020-05-07       Impact factor: 15.470

Review 6.  Genetic Therapies for Hearing Loss: Accomplishments and Remaining Challenges.

Authors:  Shahar Taiber; Karen B Avraham
Journal:  Neurosci Lett       Date:  2019-10-03       Impact factor: 3.046

7.  Inner ear gene transfection in neonatal mice using adeno-associated viral vector: a comparison of two approaches.

Authors:  Li Xia; Shankai Yin; Jian Wang
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

8.  Virally expressed connexin26 restores gap junction function in the cochlea of conditional Gjb2 knockout mice.

Authors:  Q Yu; Y Wang; Q Chang; J Wang; S Gong; H Li; X Lin
Journal:  Gene Ther       Date:  2013-11-14       Impact factor: 5.250

9.  Lentivirus carrying the Atoh1 gene infects normal rat cochlea.

Authors:  Song Pan; Jingzhi Wan; Shaosheng Liu; Song Zhang; Hao Xiong; Jun Zhou; Wu Xiong; Kunfei Yu; Yong Fu
Journal:  Neural Regen Res       Date:  2013-06-15       Impact factor: 5.135

Review 10.  Practical aspects of inner ear gene delivery for research and clinical applications.

Authors:  Sungsu Lee; Anna Dondzillo; Samuel P Gubbels; Yehoash Raphael
Journal:  Hear Res       Date:  2020-03-06       Impact factor: 3.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.